Blog / Archives
Geopolitical Uncertainty Curbs Biotech Stock Gains: Update-1
Update-1 1/9/20 "Sigh of Relief" rally for second day -Don't Fight the FED Dont confuse a momentum rally with fundamental analysis as we are at new highs with market PEs>18. Large cap biiopharmas...
Biotech Stocks Make Q4 Comeback in 2019: Our Calls Were Excellent….Update-4 Biotechs are lagging
Update-4 January 2 , 2020. 12:11 EST..... Biotechs and Healthcare lagging a bit in the New Year. Watch rotation into other sectors -tech, financial, energy; update at end of week. Many mid and...
Update—Later Today…Site Problems yesterday? update 12/21
update 12/21...Looks like all problems have been cleared and content visible. ====== You may have experienced site problems yesterday related to hosting but all content should be available today;...
Rayno Life Science Portfolio Updates-AMRN GNMK TDOC ; XBI is up 30% YTD…Update-12/17
Update-12/17. Amarin (AMRN)- A Sell on the News? AMRN stock tanked another 6.7% today on last weekend's news of the FDA approval of VASCEPA. This is what happens with momentum stocks with a well...
Two Early Stage Biopharma Deals Focus on Oncology Assets…ARQL THOR…Update-1
Update-1 ...12/12/19...China Deal Announcement Boosts Dow S&P and NASDAQ. IBB up 0.68%, XBI up 0.58%, XLV up 0.93%. Large cap leaders: ABBV ALXN BMY, Chips, energy, financials strong; real...
Biotech Scoreboard-November: Gene Therapy Stocks Gain Momentum…Update-2– BOLD
Update-2 ...12/3...Biotech among the leading sectors on a sell-off day With NASDAQ off 0.55% and the S&P down 0.68%, biotech stocks were oblivious to the trade worries and had a huge rally...
Rayno BioBeat #3: Sentiment Shift Boosts Biotech and Healthcare Stocks Despite Political Undertow…Update-1 “green screen”
Update-1 11/25/19... Rally right on track driven by NVS/MDCO deal, new product surge and cheap money from FED. As we said many time on this site XBI is the bellwether up 4.25% today (UP 13% in one...
Healthcare Stocks Breakout and Biotech Stocks Rally Off the Bottom…Update-3 ALNY AMRN
Update-3 10/20...China Phase 1 deal stalled -curbs strong momentum in biopharma. Amarin (AMRN) getting beat up by an Oppenheimer skeptic who thinks Vascepa growth will be tepid. Despite tape...
Nice Gains for Biotech Today Big and Small…Update-2
Update-2...One of the best days of the year for us; I will summarize later. Only laggard sector was speculative microcaps. Some of our best gains among healthcare/life science stocks: ABBV AMRN CRSP...
Biotech and Healthcare Stocks Notch-Up with Bullish Tape Action
Biotech and Healthcare Stocks Notch -Up with Bullish Tape Action Since we called the early October reversal for healthcare and biotech stocks we have seen great gains of 5-7% with more gains ahead...